These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 30198401)

  • 21. Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis.
    Liu B; Zhang J; Huang C; Liu H
    PLoS One; 2012; 7(8):e43147. PubMed ID: 22912812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma.
    Kwon JH; Ahn KS; Moon YH; Park JY; Wang HJ; Choi KY; Kim G; Joh JW; Lee KG; Kang KJ
    J Korean Med Sci; 2015 Sep; 30(9):1253-9. PubMed ID: 26339164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Senescence marker protein 30 (SMP30) serves as a potential prognostic indicator in hepatocellular carcinoma.
    Mo Z; Zheng S; Lv Z; Zhuang Y; Lan X; Wang F; Lu X; Zhao Y; Zhou S
    Sci Rep; 2016 Dec; 6():39376. PubMed ID: 27991558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of nuclear PGAM2 value in hepatocellular carcinoma prognosis.
    Li YR; Chen JD; Zhu YY; Li JT; Jin GZ; Jin RM
    Anticancer Drugs; 2022 Jan; 33(1):e500-e506. PubMed ID: 34321420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma.
    Wang CH; Li M; Liu LL; Zhou RY; Fu J; Zhang CZ; Yun JP
    Oncotarget; 2015 Dec; 6(39):42118-29. PubMed ID: 26517349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.
    Zhang J; Song Q; Liu J; Lu L; Xu Y; Zheng W
    Dis Markers; 2019; 2019():8964015. PubMed ID: 31781310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
    He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J
    Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
    Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
    World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma.
    Hu X; He B; Zhou L; Xie H; Zheng S
    Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of Anxa2 and Stat3 promote progression of hepatocellular carcinoma and predict poor prognosis.
    Tang L; Liu JX; Zhang ZJ; Xu CZ; Zhang XN; Huang WR; Zhou DH; Wang RR; Chen XD; Xiao MB; Qu LS; Lu CH
    Pathol Res Pract; 2019 Jun; 215(6):152386. PubMed ID: 30935762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma.
    Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY
    Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
    Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
    Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Liu J; Ni W; Qu L; Cui X; Lin Z; Liu Q; Zhou H; Ni R
    Dig Dis Sci; 2016 Sep; 61(9):2554-67. PubMed ID: 27221498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [High expression of thrombin receptor PAR1 in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma in early stage].
    Zhang XF; Dong QZ; Xue YH; Zhou HJ; Ye QH; Ren N; Jia HL; Qin LX
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):266-70. PubMed ID: 21586224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.
    Yang SL; Liu LP; Jiang JX; Xiong ZF; He QJ; Wu C
    Jpn J Clin Oncol; 2014 Feb; 44(2):159-67. PubMed ID: 24374892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.